Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy: A Multicenter, Randomized Controlled Trial.

NCT06293287 is registered in ClinicalTrials.gov with Zhongshan Hospital (Xiamen), Fudan University as lead sponsor.

NCT NCT06293287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06293287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy: A Multicenter, Randomized Controlled Trial.
Lead sponsor
Zhongshan Hospital (Xiamen), Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2024
Completion date
January 30, 2025
Enrollment
156 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radial artery occlusion